Stock listing

Molecular Partners Ag

Selected listing: MOLN · SIX · CHF · CH

Molecular Partners Ag (SIX Swiss: MOLN), Health Technology. Latest release Aug 25, 2026: Molecular Partners Reports H1 2026 Financial Results and Corporate…

MOLN:SIXCHFCHUpdated October 2, 2026

Ticker: SIX Swiss: MOLN
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: SIX Swiss
Currency: CHF

About Molecular Partners Ag

Molecular Partners AG is a public company based in Switzerland, trading under the ticker MOLN. Molecular Partners focuses on developing innovative therapies based on its proprietary DARPins technology platform.

Latest news from Molecular Partners Ag

Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study

August 25, 2026

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

July 16, 2026

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

July 15, 2026

Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

July 6, 2026

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

July 2, 2026

All Molecular Partners Ag news →

Events

Replays

Molecular Partners AG (MOLN) Q2 2024 Earnings Call
Tue, Aug 27, 2024 · 08:00 AM ET
Watch
Molecular Partners AG (MOLN) Q4 2023 Earnings Call
Fri, Mar 15, 2024 · 08:00 AM ET
Watch
Molecular Partners AG (MOLN) Q4 2022 Earnings Call
Fri, Mar 10, 2023 · 11:00 AM ET
Watch

Research Molecular Partners Ag

Molecular Partners Ag company profile

View the public company page for Molecular Partners Ag on 6ix.

Molecular Partners Ag news

Read company news and market updates connected to Molecular Partners Ag.

Molecular Partners Ag investor events

Find investor webinars, events, and replay context for Molecular Partners Ag.